GSK256073 is a potent, selective, and orally active agonist of GPR109A, as well as a persistent HCA2 agonist that significantly improves glucose homeostasis by inhibiting lipid degradation, with potential for the study of type 2 diabetes mellitus (T2DM) and dyslipidemia.
- Size: 1mg
- Purity: ≥98%
- Brand: Saint Michael
- Catalogue No.: IG6160-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review